Abstract

Introductiontuberculosis (TB) is one of the leading causes of morbidity and mortality among people living with HIV/AIDS. The growing burden of TB/HIV co-infection continues to strain the healthcare system due to association with long duration of treatment. This is a catalyst for poor adherence to clinic appointments, which results in poor treatment adherence and patient outcome. This study evaluated the factors associated with adherence to clinic appointments among TB/HIV co-infected patients in Johannesburg, South Africa.Methodsthis was a cross-sectional study that involved 10427 patients ≥18 years of age with HIV infection and co-infected with TB. We used a proxy measure “md clinic appointments” to assess adherence, then multivariable logistic regression to evaluate factors associated with adherence.Resultsone thousand, five hundred and twenty-eight patients were co-infected with TB, of these, 17.4% attained good adherence. Patients with TB/HIV co-infection who were on treatment for a longer period were less likely to adhere to clinic appointments (AOR: 0.98 95% CI: 0.97, 0.99).Conclusionduration on treatment among TB/HIV co-infected patients is associated with adherence to clinic appointments. It is therefore vital to reinforce public health interventions that would enhance sustained adherence to clinic appointments and mitigate its impact on treatment adherence and patient outcome.

Highlights

  • Tuberculosis (TB) remains a major public health challenge, which has been compounded over the past four decades by the Human Immunodeficiency Virus (HIV) epidemic [1]

  • There was a significant association between adherence to clinic appointments and WHO stage of HIV diseases at baseline (p

  • We found that there was a significant association between and adherence to clinic appointments (Table 2)

Read more

Summary

Introduction

Tuberculosis (TB) remains a major public health challenge, which has been compounded over the past four decades by the Human Immunodeficiency Virus (HIV) epidemic [1]. As the prevalence of HIV continues to increase, the proportion of individuals in the population with compromised immune system increased leading to an increase in TB cases [1]. In 2014, TB was the leading infectious cause of death [2] and the most common opportunistic infection among people living with HIV infection (PLWH) [3,4,5]. In the presence of a weakened immune system, Mycobacterium tuberculosis progressively multiplies and causes TB. An individual with TB/HIV co-infection has a higher likelihood of developing active TB [7,8]. The TB/HIV co-infection has significantly increased the burden of infectious diseases worldwide [3]

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call